MATINAS BIOPHARMA HOLDINGS, INC. Goodwill
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Goodwill of $1.34 million as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2026-03-31
- 2024-09-30: Goodwill $1.34M.
- 2024-06-30: Goodwill $1.34M.
- 2024-03-31: Goodwill $1.34M.
- 2023-12-31: Goodwill $1.34M.
| Period end | Goodwill | Goodwill as first filed |
|---|---|---|
| 2024-09-30 | $1.34M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.34M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.34M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.34M 10-K · filed 2026-03-31 | |
| 2023-09-30 | $1.34M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $1.34M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $1.34M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $1.34M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $1.34M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $1.34M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.34M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.34M 10-K · filed 2023-03-15 | $1.34M 10-K · filed 2022-03-08 |
| 2021-09-30 | $1.34M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $1.34M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $1.34M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $1.34M 10-K/A · filed 2022-03-11 | |
| 2020-09-30 | $1.34M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $1.34M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.34M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.34M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $1.34M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $1.34M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $1.34M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $1.34M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $1.34M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $1.34M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.34M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $1.34M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $1.34M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $1.34M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $1.34M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $1.34M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $1.34M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.34M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $1.34M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $1.34M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $1.38M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $1.38M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $1.38M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |